Accurate Wealth Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Other funds holding AZN
RG
CDDEC
BTCPP
AAMU
AIM
AV
Accurate Wealth Management's AZN Position: Q2 2026 in Review
Accurate Wealth Management increased its AstraZeneca (AZN) stake by 0.68% in Q2 2026, buying an estimated $5.64K and bringing the position to 4,440 shares worth $763K. The position accounts for 0.07% of the portfolio, ranked #262.
Accurate Wealth Management first reported a position in AZN in Q4 2022 and has held it in 15 quarters since. The position peaked at $900K in Q1 2026. 502 funds tracked by Wall St. Rank hold AZN as of Q2 2026.
- Accurate Wealth Management held 4,440 shares of AstraZeneca worth $763K as of Q2 2026.
- Accurate Wealth Management bought 30 AstraZeneca shares in Q2 2026, an estimated $5.64K.
- AstraZeneca made up 0.07% of Accurate Wealth Management's portfolio in Q2 2026, its #262 holding.
- Accurate Wealth Management first reported a position in AstraZeneca in Q4 2022 and has held it in 15 quarters since.
- Accurate Wealth Management's AstraZeneca position peaked at $900K in Q1 2026.
- 502 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.
Based on Accurate Wealth Management's 13F filing for Q2 2026, filed 15 Jul 2026.